Clinical Scorecard: Hypertension’s Earliest Ocular Signs?
At a Glance
| Category | Detail |
|---|---|
| Condition | Stage 1 primary hypertension and choriocapillaris microvascular findings in children |
| Key Mechanisms | OCT angiography showed a greater proportion of non-perfused choriocapillaris area in hypertensive children; the study did not establish the timing or mechanism of this association. |
| Target Population | Children aged 6–18 years with stage 1 primary hypertension, compared with age- and sex-comparable healthy controls |
| Care Setting | Prospective cross-sectional ophthalmic imaging study; participants had no clinically detectable ocular disease, and hypertensive participants were untreated at enrollment. |
Key Highlights
- The study included 94 children with stage 1 primary hypertension and 60 healthy controls.
- Visual acuity and clinical ocular examinations were normal in all participants.
- Retinal and optic nerve OCTA measures and conventional OCT measures showed no significant group differences.
- Non-perfused choriocapillaris area was significantly greater in the hypertensive group across all three measured regions.
- After adjustment for age, sex, and BMI, hypertension remained independently associated with greater non-perfused area in the two outer regions.
Guideline-Based Recommendations
Diagnosis
- The study assessed ocular findings using OCT, OCTA, visual acuity, intraocular pressure measurement, and anterior and posterior segment examination.
- No clinically detectable ocular disease was found in the hypertensive children.
Management
- The study authors recommend larger longitudinal cohort studies to clarify the temporal relationship between choriocapillaris changes and systemic hypertension.
- The article does not establish OCTA-derived non-perfused area as a clinical diagnostic test or provide treatment recommendations.
Monitoring & Follow-up
- The authors state that OCTA-derived non-perfused choriocapillaris area could potentially serve as a noninvasive marker and help identify children warranting closer systemic and ophthalmic surveillance; this requires confirmation.
Risks
- The cross-sectional design and lack of longitudinal or detailed ambulatory blood-pressure data limit conclusions about timing and causality.
- Axial length was not measured, the automated non-perfusion algorithm was not specifically validated in children, and residual metabolic confounding cannot be excluded.
Patient & Prescribing Data
Ninety-four children aged 6–18 years with stage 1 primary hypertension, followed for at least one year and not receiving antihypertensive treatment at enrollment; 60 age- and sex-comparable healthy controls.
No treatment was evaluated. Hypertensive participants were untreated at enrollment.
Clinical Best Practices
- Interpret the reported OCTA findings in light of the study’s cross-sectional design and stated measurement limitations.
- Do not treat increased choriocapillaris non-perfusion as an established clinical marker on the basis of this study alone.
- The study authors call for larger longitudinal studies to assess the temporal relationship between hypertension and choriocapillaris alterations.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
